China National Accord Medicines Corporation Ltd.

Shenzhen Stock Exchange 000028.SZ

China National Accord Medicines Corporation Ltd. Gross Profit Margin for the year ending December 31, 2023: 11.93%

China National Accord Medicines Corporation Ltd. Gross Profit Margin is 11.93% for the year ending December 31, 2023, a -1.82% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.
  • China National Accord Medicines Corporation Ltd. Gross Profit Margin for the year ending December 31, 2022 was 12.15%, a 3.61% change year over year.
  • China National Accord Medicines Corporation Ltd. Gross Profit Margin for the year ending December 31, 2021 was 11.73%, a -0.86% change year over year.
  • China National Accord Medicines Corporation Ltd. Gross Profit Margin for the year ending December 31, 2020 was 11.83%, a 7.03% change year over year.
  • China National Accord Medicines Corporation Ltd. Gross Profit Margin for the year ending December 31, 2019 was 11.05%, a -6.50% change year over year.
Key data
Date Gross Profit Margin Operating Income Margin EBT Margin Net Income Margin
Market news
Shenzhen Stock Exchange: 000028.SZ

China National Accord Medicines Corporation Ltd.

CEO Mr. Zhaoxiong Lin MBA
IPO Date June 8, 1993
Location China
Headquarters Accord Pharm. Building
Employees 39,449
Sector Health Care
Industries
Pharmaceuticals Drugstores & Retail Pharmacies
Description

China National Accord Medicines Corporation Ltd. engages in the distribution of medicine and pharmaceutical products. The company sells Chinese traditional, bio-chemical, biological, and diagnosis medicines, as well as antibiotics; chemical preparations; food products; chemical products; and various commodities. It also engages in the sale of medical apparatus and instruments; provision of freight transportation, storage, loading and unloading, and professional consultation services; provision of glass wares, cosmetics, and daily merchandise, as well as goods agency services; import and export of technology; leasing of house properties; and wholesale and retail of health products. As of December 31, 2021, the company operated a network of 8,798 drugstores, including 7,257 directly owned stores and 1,541 franchised stores covering 20 provinces, autonomous regions, and municipalities in China. The company was founded in 2004 and is based in Shenzhen, China. China National Accord Medicines Corporation Ltd. is a subsidiary of Sinopharm Group Co., Ltd.

StockViz Staff

January 16, 2025

Any question? Send us an email